622 SAFETY, AND TOLERABILITY OF NIM811, A NOVEL CYCLOPHILIN INHIBITOR FOR HCV, FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND HCV-INFECTED PATIENTS

詳細情報 詳細情報について

• CRID

  1364233270926215040

• DOI

  10.1016/s0168-8278(09)60624-3

• ISSN

  01688278

• Web Site

  https://api.elsevier.com/content/article/PII:S0168827809606243?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0168827809606243?httpAccept=text/plain

• データソース種別

  • Crossref